TNF and rheumatoid arthritis: Golimumab (GOM), a humanized monoclonal antibody against TNF-α is effective and generally well-tolerated when administered in combination with MTX to patients with moderate to severe RA.9 The aim of the present study was to establish the influence of GOM in combination with MTX on the antibody response to vaccination with PPSV23.